Mark E Bigler, MD - Medicare Urology in Bowling Green, KY

Mark E Bigler, MD is a medicare enrolled "Urology" physician in Bowling Green, Kentucky. He went to Vanderbilt University School Of Medicine and graduated in 1989 and has 35 years of diverse experience with area of expertise as Urology. He is a member of the group practice Gilbert Barbee Moore And Mcilvoy Psc and his current practice location is 201 Park St, Bowling Green, Kentucky. You can reach out to his office (for appointments etc.) via phone at (270) 783-3343.

Mark E Bigler is licensed to practice in Kentucky (license number 30606) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1073517066.

Contact Information

Mark E Bigler, MD
201 Park St,
Bowling Green, KY 42101-1759
(270) 783-3343
(270) 780-0476



Physician's Profile

Full NameMark E Bigler
GenderMale
SpecialityUrology
Experience35 Years
Location201 Park St, Bowling Green, Kentucky
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mark E Bigler attended and graduated from Vanderbilt University School Of Medicine in 1989
  NPI Data:
  • NPI Number: 1073517066
  • Provider Enumeration Date: 06/08/2005
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 3678600525
  • Enrollment ID: I20100423000673

Medical Identifiers

Medical identifiers for Mark E Bigler such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1073517066NPI-NPPES
64306061MedicaidKY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 30606 (Kentucky)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
The Medical Center (bowling Green)Bowling green, KYHospital
Greenview Regional HospitalBowling green, KYHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Gilbert Barbee Moore And Mcilvoy Psc4082511167223

News Archive

International Symposium to explore Hybrid approach for congenital heart disease

Interventional cardiologists and cardiothoracic surgeons throughout the United States and the world, who treat patients with congenital heart disease, will gather at the Hilton Columbus at Easton Town Center August 31-September 2, 2010 for the International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC).

ConjuChem Biotechnologies completes non-dilutive capital transaction

ConjuChem Biotechnologies Inc. ("ConjuChem") (TSX:CJB) today announced the completion of the transaction providing $5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.

Clinical study investigates lifestyle biomarkers in prostate cancer survivors

Advanced glycation end products, which have been linked to many chronic diseases, including diabetes, cardiovascular disease and cancer, build up in the body from birth due to normal metabolism but are often higher in those eating the high-fat, high-sugar, highly processed foods characteristic of the Western diet.

Research shows depletion of cholesteryl ester impairs prostate cancer aggressiveness

Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.

Study evaluates long-term safety of infants after maternal MRI exposure

In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mark E Bigler allows following entities to bill medicare on his behalf.
Entity NameGilbert Barbee Moore & Mcilvoy Psc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1114948288
PECOS PAC ID: 4082511167
Enrollment ID: O20031217000136

News Archive

International Symposium to explore Hybrid approach for congenital heart disease

Interventional cardiologists and cardiothoracic surgeons throughout the United States and the world, who treat patients with congenital heart disease, will gather at the Hilton Columbus at Easton Town Center August 31-September 2, 2010 for the International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC).

ConjuChem Biotechnologies completes non-dilutive capital transaction

ConjuChem Biotechnologies Inc. ("ConjuChem") (TSX:CJB) today announced the completion of the transaction providing $5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.

Clinical study investigates lifestyle biomarkers in prostate cancer survivors

Advanced glycation end products, which have been linked to many chronic diseases, including diabetes, cardiovascular disease and cancer, build up in the body from birth due to normal metabolism but are often higher in those eating the high-fat, high-sugar, highly processed foods characteristic of the Western diet.

Research shows depletion of cholesteryl ester impairs prostate cancer aggressiveness

Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.

Study evaluates long-term safety of infants after maternal MRI exposure

In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mark E Bigler is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mark E Bigler, MD
201 Park St,
Bowling Green, KY 42101-1759

Ph: (270) 783-3343
Mark E Bigler, MD
201 Park St,
Bowling Green, KY 42101-1759

Ph: (270) 783-3343

News Archive

International Symposium to explore Hybrid approach for congenital heart disease

Interventional cardiologists and cardiothoracic surgeons throughout the United States and the world, who treat patients with congenital heart disease, will gather at the Hilton Columbus at Easton Town Center August 31-September 2, 2010 for the International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC).

ConjuChem Biotechnologies completes non-dilutive capital transaction

ConjuChem Biotechnologies Inc. ("ConjuChem") (TSX:CJB) today announced the completion of the transaction providing $5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.

Clinical study investigates lifestyle biomarkers in prostate cancer survivors

Advanced glycation end products, which have been linked to many chronic diseases, including diabetes, cardiovascular disease and cancer, build up in the body from birth due to normal metabolism but are often higher in those eating the high-fat, high-sugar, highly processed foods characteristic of the Western diet.

Research shows depletion of cholesteryl ester impairs prostate cancer aggressiveness

Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.

Study evaluates long-term safety of infants after maternal MRI exposure

In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.

Read more News

› Verified 1 days ago


Urology Doctors in Bowling Green, KY

Dr. Samer Rida Kalakish, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 201 Park St, Bowling Green, KY 42101
Phone: 270-781-5111    Fax: 270-780-0498
Clark Lewis Carthrae, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 1227 Ashley Circle, Bowling Green, KY 42104
Phone: 270-781-1354    Fax: 270-781-7308
Dr. Matthew E Rutter, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 201 Park St, Bowling Green, KY 42101
Phone: 270-781-5111    Fax: 270-780-0498
J Roger Goodwin, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 1325 Andrea St, Suite 201, Bowling Green, KY 42104
Phone: 270-781-7212    Fax: 270-781-7772
David Anthony Bergamini, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 201 Park St, Bowling Green, KY 42101
Phone: 270-781-5111    Fax: 270-780-0476

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.